ARTICLE | Company News
Draxis, Eli Lilly Canada Inc. sales and marketing update
September 20, 2010 7:00 AM UTC
DRAXF renewed its exclusive license for Canadian marketing of Lilly's Permax pergolide mesylate to treat Parkinson's disease. Lilly will manufacture Permax and supply it to DRAXF for an additional 10...